PainReform Ltd. (PRFX:NASDAQ) rocketted at $0.55, representing a gain of 27.1%. On Fri, Jun 30, 2023, PRFX:NASDAQ touched a New 2-Week High of $0.55. The stock got featured on our News Catalysts scanner on Thu, Jun 15, 2023 at 08:50 AM in the 'MISCELLANEOUS' category. From Fri, Jun 16, 2023, the stock recorded 33.33% Up Days and 20.00% Green Days
The stock spiked on Wed, Feb 08, 2023 at $0.82 with a volume of 13M+.
About PainReform Ltd. (PRFX:NASDAQ)
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics.
Top 10 Gainers:
- Viveve Medical, Inc. (VIVE:NASDAQ), 2900%
- Baudax Bio, Inc. (BXRX:NASDAQ), 124.91%
- VBI Vaccines Inc. (VBIV:NASDAQ), 75%
- Renalytix AI plc (RNLX:NASDAQ), 43.84%
- CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 39.67%
- Rackspace Technology Inc. (RXT:NASDAQ), 38.78%
- Cyteir Therapeutics Inc. (CYT:NASDAQ), 35.42%
- Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ), 27.98%
- PainReform Ltd. (PRFX:NASDAQ), 27.06%
- Gracell Biotechnologies Inc. (GRCL:NASDAQ), 27%